trial · primary record
Intranasal Oxytocin (IN-OXT) 6 IU single dose
Vasopressin Deficiency
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2027-06 |
| Primary endpoint | Dot-probe task - anxious behavior between low dose oxytocin and placebo |
| Registry ID | NCT04789148 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:13.108Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04789148
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.